by HBOT News | Feb 10, 2016 | Chronic Wounds
Abstract: Significance: Broad-spectrum metalloproteinase (MMP) reduction along with inherent aspects of an extracellular matrix (ECM) dressing can bring about improved wound healing outcomes and shorter treatment duration. Initial reports of clinical effectiveness of...
by HBOT News | Jan 8, 2016 | Central Retinal Artery Occlusion (CRAO)
Abstract: A 43-year-old male presented with sudden onset of painless, blurred vision in his left eye. Dilated fundoscopic examination showed signs consistent with the diagnosis of a combination of central retinal vein occlusion (CRVO) and cilioretinal artery occlusion...
by HBOT News | Oct 7, 2015 | Clinical Trials, HBOT Research, Periampullary Tumor
The primary objective of this study is to assess the safety, tolerability and toxicity of
preoperative HBOT in patients undergoing a pancreaticoduodenal resection for premalignant and
malignant tumors of the common bile duct, periampullary and duodenum.
by HBOT News | Aug 18, 2015 | Central Retinal Artery Occlusion (CRAO)
Abstract: Central retinal artery occlusion (CRAO) is an ocular emergency and most of the cases present with painless sudden persistent loss of vision in the range of counting fingers to perception of light. The presentation of CRAO is associated with a variety of...
by HBOT News | Jun 23, 2015 | Macular Degeneration
Abstract: Choroidal neovascularization (CNV) is one of the leading causes of blindness worldwide and affects patients with wet age-related macular degeneration (AMD). Its natural course may lead to impaired central vision and macular fibrosis. Even VEGF blockade,...
